QurieGen Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 14

QurieGen General Information

Description

Developer of a cancer treatment drug designed to comprehend the fundamental cellular mechanisms driving diseases. The company specializes in proprietary methods of mapping cellular responses, single-cell genomics, and data science to build predictive models of disease biology and drug response, enabling clients to identify new drug targets, develop effective therapies, and reduce the time and cost associated with traditional drug discovery and development.

Contact Information

Website
www.quriegen.com
Formerly Known As
Monoceros Analytics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Heyendaalseweg 135
  • 6525 AJ Nijmegen
  • Netherlands
Primary Industry
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Heyendaalseweg 135
  • 6525 AJ Nijmegen
  • Netherlands

QurieGen Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

QurieGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Accelerator/Incubator 01-Sep-2026 Completed Generating Revenue
7. Seed Round 08-Apr-2025 Completed Generating Revenue
6. Accelerator/Incubator 12-Dec-2024 Completed Startup
5. Accelerator/Incubator 25-May-2022 Completed Startup
4. Accelerator/Incubator 01-Apr-2022 Completed Startup
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-Apr-2022 Completed Startup
To view QurieGen’s complete valuation and funding history, request access »

QurieGen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

QurieGen Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
MassBio Accelerator/Incubator
22 Hor Invest Venture Capital Minority
BSV Ventures Venture Capital Minority
Draper Associates Venture Capital Minority
Lighthouse Ventures (Prague) Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

QurieGen FAQs

  • When was QurieGen founded?

    QurieGen was founded in 2022.

  • Where is QurieGen headquartered?

    QurieGen is headquartered in Nijmegen, Netherlands.

  • What is the size of QurieGen?

    QurieGen has 9 total employees.

  • What industry is QurieGen in?

    QurieGen’s primary industry is Drug Discovery.

  • Is QurieGen a private or public company?

    QurieGen is a Private company.

  • What is QurieGen’s current revenue?

    The current revenue for QurieGen is .

  • How much funding has QurieGen raised over time?

    QurieGen has raised $2.52M.

  • Who are QurieGen’s investors?

    MassBio, 22 Hor Invest, BSV Ventures, Draper Associates, and Lighthouse Ventures (Prague) are 5 of 14 investors who have invested in QurieGen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process